Form 4: Orthopediatrics GC Sells Shares for Tax Obligations

Orthopediatrics General Counsel Daniel J. Gerritzen reported an acquisition of shares followed by a sale to cover tax withholding obligations.

Summary

• Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp. (KIDS), reported changes in his beneficial ownership.
• On March 15, 2026, Mr. Gerritzen acquired 47,380 shares of Common Stock at a price of $0, likely due to the vesting of restricted shares.
• Following this acquisition, his beneficial ownership stood at 158,147 shares.
• On March 16, 2026, he disposed of 8,614 shares of Common Stock at a price of $17.25 per share.
• This sale was explicitly stated to satisfy tax withholding obligations upon the vesting of restricted shares.
• After these transactions, Mr. Gerritzen's beneficial ownership is 149,533 shares, which includes 121,054 restricted stock awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The transactions represent routine executive compensation and tax planning, which are common and generally do not indicate a significant shift in company fundamentals or executive sentiment.

Positives

• The acquisition of 47,380 shares at $0 indicates the vesting of equity awards, aligning management's interests with shareholders.
• The significant portion of remaining beneficial ownership (149,533 shares, including 121,054 restricted shares) demonstrates continued long-term commitment from a key executive.

Negatives

• A reduction of 8,614 shares in direct beneficial ownership, even if for tax purposes, represents a decrease in the executive's direct stake.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that Form 4 filings are specific to individual insider transactions and do not typically provide broader industry trends or competitive analysis.

Comparison to Industry Standards

• StockSavvy.ai notes that the reported transactions are routine for executive compensation and tax planning, making direct comparisons to specific industry benchmarks or competitor projects less relevant for this type of filing.

Stakeholder Impact

• Shareholders: Minimal impact, as these are routine insider transactions related to executive compensation and tax obligations, not indicative of a change in company strategy or performance.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The reported transactions are routine insider activities related to executive compensation and tax management. They do not provide new fundamental information about Orthopediatrics Corp. that would warrant a change in investment recommendation. Investors should continue to hold based on broader company performance and market conditions.

Keywords

Orthopediatrics, KIDS, Insider Trading, Form 4, Beneficial Ownership, Restricted Stock, Tax Withholding, Executive Compensation